Insider Ownership
| Role | Insider | Shares | Value | 30d |
|---|
| Dir | Wang Xiaodong | 4.58M | $1.56B | - |
| Pres | Wang Lai | 1.45M | $494.04M | - |
| Dir | BAKER BROS. ADVISORS LP | 148.1K | $50.40M | - |
| Dir | HOOPER ANTHONY C | 64.7K | $22.04M | - |
| Dir | Riva Alessandro | 56.9K | $19.38M | - |
Transactions
9 filings · page 19
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|
| 2020-09-29 | OYLER JOHN | Chief Executive Officer | Sell | 53,103 | $280.54 | $14,897,734.33 | -30.0% | → |
| 2020-09-25 | Wang Xiaodong | - | Sell | 5,000 | $280.42 | $1,402,116.31 | -89.0% | → |
| 2020-09-25 | Wu Xiaobin | President & GM China | Sell | 4,000 | $280.35 | $1,121,406.00 | -100% | → |
| 2020-09-17 | Wang Xiaodong | - | Sell | 5,000 | $260.27 | $1,301,355.95 | -98.3% | → |
| 2020-09-17 | Wu Xiaobin | President & GM China | Sell | 4,000 | $260.33 | $1,041,326.90 | -88.9% | → |
| 2020-09-16 | OYLER JOHN | Chief Executive Officer | Sell | 81,228 | $253.46 | $20,587,969.07 | -34.2% | → |
| 2020-09-14 | Liang Howard | CFO & Chief Strategy Officer | Sale+OE | 14,000 | $250.27 | $3,503,763.52 | -29.6% | → |
| 2020-09-03 | Huang Jane | CMO, Hematology | Sell | 3,128 | $233.07 | $729,045.04 | -50.5% | → |
| 2020-09-02 | OYLER JOHN | Chief Executive Officer | Sell | 7,137 | $227.16 | $1,621,264.16 | -11.7% | → |